Pipeline 1: Antibody Optimization and Development (New!)
With biologic drugs becoming more prominent in the marketplace, antibody researchers are now turning their attention to new indications, improved targeting, new formats and products that are truly differentiated relative to competitors. The new Antibody Optimization and Development pipeline offers a valuable, weeklong exploration of state-of-the-art approaches for improving the fundamental quality and efficacy of therapeutic antibodies - and for maximizing their potential as marketed drug products.
Enhancing Antibody Binding and Specificity
Improving the Clinical Efficacy of Antibody Therapeutics
Turning Antibodies into Drug Products